Abstract:Background and purpose: Expression of the pro-fibrotic galectin-3 and the pro-apoptotic BIM is elevated in diseased heart or after β-adrenoceptor stimulation, but the underlying mechanisms are unclear. This question was addressed in the present study. Experimental approach: Wild-type mice and mice with cardiac transgenic expression of β2 -adrenoceptors, mammalian sterile-20 like kinase 1 (Mst1) or dominant-negative Mst1, and non-specific galectin-3 knockout mice were used. Effects of the β-adrenoceptor agonist isoprenaline or β-adrenoceptor antagonists were studied. Rat cardiomyoblasts (H9c2) were used for mechanistic exploration. Biochemical assays were performed. Key results: Isoprenaline treatment up-regulated expression of galectin-3 and BIM, and this was inhibited by non-selective or selective β-adrenoceptor antagonists (by 60-70%). Cardiac expression of galectin-3 and BIM was increased in β2 -adrenoceptor transgenic mice. Isoprenaline-induced up-regulation of galectin-3 and BIM was attenuated by Mst1 inactivation, but isoprenaline-induced galectin-3 expression was exaggerated by transgenic Mst1 activation. Pharmacological or genetic activation of β-adrenoceptors induced Mst1 expression and yes-associated protein (YAP) phosphorylation. YAP hyper-phosphorylation was also evident in Mst1 transgenic hearts with up-regulated expression of galectin-3 (40-fold) and BIM as well as up-regulation of many YAP-target genes by RNA sequencing. In H9c2 cells, isoprenaline induced YAP phosphorylation and expression of galectin-3 and BIM, effects simulated by forskolin but abolished by PKA inhibitors, and YAP knockdown induced expression of galectin-3 and BIM. Conclusions and implications: Stimulation of cardiac β-adrenoceptors activated the Mst1/Hippo pathway leading to YAP hyper-phosphorylation with enhanced expression of galectin-3 and BIM. This signalling pathway would have therapeutic potential. Linked articles: This article is part of a themed section on Adrenoceptors-New Roles for Old Players. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.14/issuetoc.

Acute β-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays G(q)-induced transcriptional activation

Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts.

CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes

Pka Phosphorylates Histone Deacetylase 5 and Prevents Its Nuclear Export, Leading to the Inhibition of Gene Transcription and Cardiomyocyte Hypertrophy

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in Cardiomyocytes upon Increased Workload

Decreased long-chain acyl-CoA dehydrogenase mediates cardiac energy deficiency and injury induced by β-adrenergic stimulation

Distinct Beta-Adrenergic Receptor Subtype Signaling in the Heart and Their Pathophysiological Relevance.

Nuclear GAPDH cascade mediates pathological cardiac hypertrophy

Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function

Internalized β2-Adrenergic Receptors Oppose PLC-Dependent Hypertrophic Signaling

JAK/STAT3 signaling pathway is involved in α1-AR-mediated cardiac hypertrophy

Protein Kinase C Activation in Cardiac Hypertrophy and Failure

Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis.

Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway

Membrane Nanotubes Facilitate the Propagation of Inflammatory Injury in the Heart Upon Overactivation of the Β-Adrenergic Receptor.

Pressure Overload-Induced Cardiac Hypertrophy Response Requires Janus Kinase 2-Histone Deacetylase 2 Signaling.

The Enigma Of Beta(2)-Adrenergic Receptor G(I) Signaling In The Heart - The Good, The Bad, And The Ugly

Subtype-specific Beta-Adrenoceptor Signaling Pathways in the Heart and Their Potential Clinical Implications.

Dual-omics reveals temporal differences in acute sympathetic stress-induced cardiac inflammation following α 1 and β-adrenergic receptors activation

Transgenic Manipulation of Beta-Adrenergic Receptor Kinase Modifies Cardiac Myocyte Contraction to Norepinephrine.